» Articles » PMID: 30571233

Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling

Overview
Journal Hypertension
Date 2018 Dec 21
PMID 30571233
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence indicates that Ang II (angiotensin II) activates STAT3 (signal transducer and activator of transcription 3) in cardiomyocytes. However, the mechanisms underlying STAT3 activation and downstream responses are not fully known. In this study, we show that Ang II caused biphasic STAT3 activation in cardiomyocytes. A rapid and early activation was mediated by direct association between TLR4 (toll-like receptor-4) and STAT3. This early activation increased IL-6 (interleukin-6) production, which in turn, induced the second STAT3 activation through the IL-6/gp130 (glycoprotein 130)/JAK2 (Janus-family tyrosine kinases 2) pathway, resulting in unregulated expression of genes for cardiac remodeling. Moreover, STAT3 inhibition or TLR4 knockout in mice protected against Ang II-induced hypertrophy, fibrosis, and cardiac functional deficits. Thus, Ang II-induced STAT3 activation in cardiomyocytes was biphasic, providing a sequential induction of IL-6 and myocardial remodeling genes, respectively. This work supports a novel mechanism on STAT3 activation in Ang II-induced cardiac dysfunction and remodeling.

Citing Articles

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II.

Cui Y, Yang Y, Tang X, Wang P, Cui J, Chen Y Front Pharmacol. 2025; 16:1555991.

PMID: 40028160 PMC: 11868102. DOI: 10.3389/fphar.2025.1555991.


JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target.

Jiang H, Yang J, Li T, Wang X, Fan Z, Ye Q Front Pharmacol. 2024; 15:1336102.

PMID: 38495094 PMC: 10940489. DOI: 10.3389/fphar.2024.1336102.


Insulin augments angiotensin II-induced myocardial fibrosis via the MEK/STAT3 pathway.

Cao N, Wang H Heliyon. 2023; 9(12):e22860.

PMID: 38125490 PMC: 10731081. DOI: 10.1016/j.heliyon.2023.e22860.


Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.

Gao Z, Bao J, Hu Y, Tu J, Ye L, Wang L Curr Drug Targets. 2023; 24(13):1009-1022.

PMID: 37691190 PMC: 10879742. DOI: 10.2174/1389450124666230907115831.


Gasdermin D affects aortic vascular smooth muscle cell pyroptosis and Ang II-induced vascular remodeling.

Fang Z, Wu G, Sheng J, Ye B, Huang Z, Xu J Heliyon. 2023; 9(6):e16619.

PMID: 37303505 PMC: 10248119. DOI: 10.1016/j.heliyon.2023.e16619.